Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

NCT01747707 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction Cancer

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: S-1

Sponsor

Chinese Academy of Medical Sciences